{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:13:56Z","timestamp":1786986836359,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clbc.2022.02.004","type":"journal-article","created":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T10:19:12Z","timestamp":1644142752000},"page":"381-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Rates and Outcomes of Breast Lesions of Uncertain Malignant Potential (B3) benchmarked against the National Breast Screening Pathology Audit; Improving Performance in a High Volume Screening Unit"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4661-1563","authenticated-orcid":false,"given":"Soha El","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rathbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurram","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Muthukumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Mylona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Roxanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2022.02.004_bib0001","unstructured":"Public Health England. National breast screening pathology audit 2020 [updated December 8th, 2020; accessed 21st August, 2021]. Available at: https:\/\/www.gov.uk\/government\/publications\/national-breast-screening-pathology-audit\/national-breast-screening-pathology-audit"},{"key":"10.1016\/j.clbc.2022.02.004_bib0002","unstructured":"Royal College of Pathologists. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. Royal College of Pathologists; 2021."},{"key":"10.1016\/j.clbc.2022.02.004_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233574","article-title":"A ten-year, single-center experience: Concordance between breast core needle biopsy\/vacuum-assisted biopsy and postoperative histopathology in B3 and B5a cases","volume":"15","author":"Elsharkawy","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2022.02.004_bib0004","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.breast.2010.12.003","article-title":"Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy","volume":"20","author":"Bianchi","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2022.02.004_bib0005","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.bjc.6603714","article-title":"Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3)","volume":"96","author":"Houssami","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2022.02.004_bib0006","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2559.2008.03158.x","article-title":"Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening","volume":"53","author":"El-Sayed","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.clbc.2022.02.004_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2019.12.009","article-title":"Three-year Trends in Diagnosis of B3 Breast Lesions and Their Upgrade Rates to Malignant Lesions","volume":"20","author":"Griffiths","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2022.02.004_bib0008","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1186\/s12885-018-4742-6","article-title":"Lesions of \"uncertain malignant potential\" in the breast (B3) identified with mammography screening","volume":"18","author":"Richter-Ehrenstein","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2022.02.004_bib0009","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00330-020-07161-5","article-title":"Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?","volume":"31","author":"Lucioni","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clbc.2022.02.004_bib0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/0284185115610931","article-title":"Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management","volume":"57","author":"Saladin","year":"2016","journal-title":"Acta Radiol"},{"key":"10.1016\/j.clbc.2022.02.004_bib0011","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-016-3935-4","article-title":"First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)","volume":"159","author":"Rageth","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2022.02.004_bib0012","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160595","article-title":"The B3 conundrum-the radiologists' perspective","volume":"90","author":"Sharma","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clbc.2022.02.004_bib0013","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2559.2003.01582.x","article-title":"Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3)","volume":"42","author":"Lee","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.clbc.2022.02.004_bib0014","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2559.2011.03786.x","article-title":"Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia","volume":"58","author":"Rakha","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.clbc.2022.02.004_bib0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejso.2018.12.008","article-title":"High risk (B3) breast lesions: What is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis","volume":"45","author":"Forester","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2022.02.004_bib0016","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12253-014-9882-7","article-title":"Non-malignant breast papillary lesions - b3 diagnosed on ultrasound\u2013guided 14-gauge needle core biopsy: analysis of 114 cases from a single institution and review of the literature","volume":"21","author":"Bianchi","year":"2015","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.clbc.2022.02.004_bib0017","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/ans.16315","article-title":"B3 lesion upgrade rates in a tertiary Australian breast center: a 8-year experience (2012-2019)","volume":"90","author":"Huang","year":"2020","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.clbc.2022.02.004_bib0018","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.breast.2016.11.007","article-title":"Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy","volume":"31","author":"Mayer","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2022.02.004_bib0019","unstructured":"National Cancer Intelligence Network. COSD v9.0 and Pathology Downloads 2020 [updated September 21st, 2020; accessed August 17th, 2021]. Available at: http:\/\/www.ncin.org.uk\/collecting_and_using_data\/data_collection\/cosd_downloads_v9."},{"key":"10.1016\/j.clbc.2022.02.004_bib0020","first-page":"217","article-title":"Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained?","volume":"9","author":"Morton","year":"2017","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.clbc.2022.02.004_bib0021","unstructured":"Lord Carter of Coles. Operational productivity and performance in English NHS acute hospitals: Unwarranted variations. 2016"},{"key":"10.1016\/j.clbc.2022.02.004_bib0022","series-title":"Breast Tumours","year":"2019"},{"key":"10.1016\/j.clbc.2022.02.004_bib0023","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.crad.2018.04.004","article-title":"NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions)","volume":"73","author":"Pinder","year":"2018","journal-title":"Clinical Radiology"},{"key":"10.1016\/j.clbc.2022.02.004_bib0024","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijsu.2017.11.005","article-title":"Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature","volume":"49","author":"Co","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.clbc.2022.02.004_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2019190748","article-title":"Upgrade Rate of Percutaneously Diagnosed Pure Atypical Ductal Hyperplasia: Systematic Review and Meta-Analysis of 6458 Lesions","volume":"294","author":"Schiaffino","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2022.02.004_bib0026","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41416-020-01182-z","article-title":"The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020","volume":"124","author":"Gathani","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2022.02.004_bib0027","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/his.12387","article-title":"Understanding diagnostic variability in breast pathology: lessons learned from an expert consensus review panel","volume":"65","author":"Allison","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.clbc.2022.02.004_bib0028","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/his.13035","article-title":"Histological features associated with diagnostic agreement in atypical ductal hyperplasia of the breast: illustrative cases from the B-Path study","volume":"69","author":"Allison","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.clbc.2022.02.004_bib0029","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jama.2015.1405","article-title":"Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens","volume":"313","author":"Elmore","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2022.02.004_bib0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12282-018-00943-2","article-title":"Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens","volume":"26","author":"Rageth","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clbc.2022.02.004_bib0031","unstructured":"Heller SL, Hudson SM, Wilkinson L. Indicators of Future Breast Cancer Risk at Prevalent Round Screen: European Society of Radiology; 2015 [updated 2015; accessed August 21st, 2021]. Available at: https:\/\/epos.myesr.org\/poster\/esr\/ecr2015\/C-1401."},{"key":"10.1016\/j.clbc.2022.02.004_bib0032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1308\/003588412X13171221498460","article-title":"Lesions of uncertain malignant potential (B3) on core biopsy in the NHS Breast Screening Programme: is the screening round relevant?","volume":"94","author":"Hunt","year":"2012","journal-title":"Ann R Coll Surg Engl"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:24:21Z","timestamp":1761513861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820922000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1526820922000398"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2022.02.004","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates and Outcomes of Breast Lesions of Uncertain Malignant Potential (B3) benchmarked against the National Breast Screening Pathology Audit; Improving Performance in a High Volume Screening Unit","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2022.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}